Kymera Therapeutics Inc. (KYMR)

KYMR trades at $57.9, 15.8% above the near-term max pain of $50 expiring Oct 17, 2025 (12 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($40-$60), signaling increased put positioning or downside protection. Key magnetic zone at 40 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for KYMR shows a downward trend from 60 to 40, indicating bearish sentiment or hedging activity. The 41% spread signals divergent expectations across timeframes. Most levels below 57.9 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.